These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat. Leadem CA, Yagenova SV. Neuroendocrinology; 1987 Feb; 45(2):109-17. PubMed ID: 3033534 [Abstract] [Full Text] [Related]
46. Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase. Heijna MH, Hogenboom F, Mulder AH, Schoffelmeer AN. Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):627-32. PubMed ID: 1321956 [Abstract] [Full Text] [Related]
47. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation. Benoliel JJ, Bourgoin S, Mauborgne A, Legrand JC, Hamon M, Cesselin F. Neurosci Lett; 1991 Apr 01; 124(2):204-7. PubMed ID: 1648690 [Abstract] [Full Text] [Related]
48. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat. Hope PJ, Fleetwood-Walker SM, Mitchell R. Br J Pharmacol; 1990 Oct 01; 101(2):477-83. PubMed ID: 2175238 [Abstract] [Full Text] [Related]
49. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids. Sutters KA, Miaskowski C, Taiwo YO, Levine JD. Brain Res; 1990 Oct 22; 530(2):290-4. PubMed ID: 1979930 [Abstract] [Full Text] [Related]
50. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin. Makman MH, Dvorkin B, Crain SM. Brain Res; 1988 Apr 05; 445(2):303-13. PubMed ID: 3370465 [Abstract] [Full Text] [Related]
51. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release. Collin E, Bourgoin S, Ferhat L, Hamon M, Cesselin F. Neurosci Lett; 1992 Jan 06; 134(2):238-42. PubMed ID: 1317026 [Abstract] [Full Text] [Related]
52. Effects of prior exposure to morphine on the opioid inhibition of the stimulated release of [3H]norepinephrine from guinea pig cortex slices. Werling LL, Brown SR, Cox BM. NIDA Res Monogr; 1986 Jan 06; 75():587-90. PubMed ID: 2829006 [Abstract] [Full Text] [Related]
53. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I, Napier TC. J Pharmacol Exp Ther; 1995 Mar 06; 272(3):1260-70. PubMed ID: 7891342 [Abstract] [Full Text] [Related]
54. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat. Miaskowski C, Taiwo YO, Levine JD. Eur J Pharmacol; 1991 Dec 03; 205(3):247-52. PubMed ID: 1667910 [Abstract] [Full Text] [Related]
55. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH, Burger DM, Wardeh G, Hogenboom F, Frankhuyzen AL. Br J Pharmacol; 1991 Feb 03; 102(2):518-22. PubMed ID: 1673074 [Abstract] [Full Text] [Related]
56. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus. Garaulet JV, Laorden ML, Milanés MV. J Pharmacol Exp Ther; 1994 Jun 03; 269(3):993-9. PubMed ID: 8014886 [Abstract] [Full Text] [Related]